It is anticipated that the rapidly emerging era of data-driven precision medicine will require the development and delivery of new protein-based tests. Despite significant advances in the use of mass spectrometry for protein quantification, the implementation of new protein signatures is proving very challenging. Some of these challenges and potential solutions will be outlined in the context the precision medicine-orientated and end user driven approach Atturos is using to develop and deliver new protein signature tests with specific intended utility in chronic diseases.
For Research Use Only. Not for use in diagnostic procedures.